
Stock Trend Analysis Report
Prepared for you on Monday, December 4, 2023.
Oncocyte Corporation (NASDAQ:OCX)
Countertrend Up (+85) - OCX is showing short-term weakness. However, look for the longer-term bullish trend to resume. As always, continue to monitor the trend score and utilize a stop order.
Is it time to buy, sell, or avoid OCX?
MarketClub looks at technical strength and momentum to determine if the timing is right for OCX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
![]() |
|||||||||||||||
|
MarketClub’s Trade Triangles for OCX
The long-term trend has been UP since Nov 21st, 2023 at 4.20
The intermediate-term trend has been UP since Nov 14th, 2023 at 2.94
The short-term trend has been DOWN since Nov 29th, 2023 at 3.90
Smart Scan Analysis for OCX
Based on our trend formula, OCX is rated as a +85 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

Open | High | Low | Price | Change |
---|---|---|---|---|
3.86 | 3.98 | 3.66 | 3.98 | +0.10 |
Prev. Close | Volume | Bid | Ask | Time |
3.88 | 10598 | 2023-12-04 15:59:50 |
52wk High | 10 | 52wk High Date | 2023-01-13 |
52wk Low | 2.08 | 52wk Low Date | 2023-11-08 |
Average Volume | 24,180 | Shares Outstanding | 8,261 |
Assets | 87,540,000M | Liabilities | 39,215,000M |
P/E Ratio | -0.38870000 |